Amifitadine
Amifitadine (also known as EB-1530 or GR-1530) is a drug that is used in scientific research. It is a triple reuptake inhibitor that affects the neurotransmitters serotonin, norepinephrine, and dopamine.
Pharmacology[edit | edit source]
Amifitadine is a triple reuptake inhibitor, meaning it inhibits the reuptake of three neurotransmitters: serotonin, norepinephrine, and dopamine. This increases the amount of these neurotransmitters in the brain, which can have various effects on mood, cognition, and other neurological functions.
History[edit | edit source]
Amifitadine was first developed by the pharmaceutical company Euthymics Bioscience, which later became known as Neurovance. The drug was initially investigated as a potential treatment for depression and attention deficit hyperactivity disorder (ADHD).
Clinical trials[edit | edit source]
In clinical trials, amifitadine has been shown to have potential as a treatment for depression and ADHD. However, further research is needed to fully understand its efficacy and safety profile.
See also[edit | edit source]
| Amifitadine Resources | ||
|---|---|---|
|
| |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
